Abstract
Pseudomonas aeruginosa is a highly adaptive opportunistic pathogen that can have serious health consequences in patients with lung disorders. Taxonomic outliers of P. aeruginosa of environmental origin have recently emerged as infectious for humans. Here, we present the first genome-wide analysis of an isolate that caused fatal haemorrhagic pneumonia. In two clones, CLJ1 and CLJ3, sequentially recovered from a patient with chronic pulmonary disease, insertion of a mobile genetic element into the P. aeruginosa chromosome affected major virulence-associated phenotypes and led to increased resistance to the antibiotics used to combat the infection. Comparative genome, proteome and transcriptome analyses revealed that this ISL3-family insertion sequence disrupted the genes for flagellar components, type IV pili, O-specific antigens, translesion polymerase and enzymes producing hydrogen cyanide. Seven-fold more insertions were detected in the later isolate, CLJ3, than in CLJ1, some of which modified strain susceptibility to antibiotics by disrupting the genes for the outer-membrane porin OprD and the regulator of β-lactamase expression AmpD. In the Galleria mellonella larvae model, the two strains displayed different levels of virulence, with CLJ1 being highly pathogenic. This study revealed insertion sequences to be major players in enhancing the pathogenic potential of a P. aeruginosa taxonomic outlier by modulating both its virulence and its resistance to antimicrobials, and explains how this bacterium adapts from the environment to a human host.
Keywords: Pseudomonas aeruginosa, adaptation, antibiotic resistance, bacterial infection, multiomics
Data Summary
All data are available. The whole-genome shotgun projects for CLJ1 and CLJ3 have been deposited at DDBJ/ENA/GenBank under accession numbers PVXJ00000000 and PZJI00000000, respectively. The raw sequencing data were deposited at NCBI’s Sequence Read Archive under accession numbers SRP170343 and SRP170410. The RNA-Seq datasets have been uploaded to GEO under identifiers GSE123106 and GSE123107. The MSy proteomics data were deposited with the ProteomeXchange Consortium via the PRIDE partner repository under dataset identifier PXD011105. These data can be accessed on https://www.ebi.ac.uk/pride/archive/. The RNA-Seq experiments were performed in accordance with the ENCODE guidelines and appropriately validated by RT-qPCR.
Impact Statement.
Bacteria employ diverse strategies to adapt to changing environments, including the infectious niche in human hosts. Pseudomonas aeruginosa adapts to establish a chronic infection in cystic fibrosis patients through small nucleotide changes in pathoadaptive genes. In this study, we demonstrate that P. aeruginosa clonal outliers use another strategy to evade the host’s immune system and to deal with the antibiotics used to treat the infection. Using a genome-wide ‘multiomics’ approach, we discovered that a single mobile genetic element belonging to the ISL3 insertion sequence family altered (i) the structure of multiple surface macromolecules (flagella, pili, lipopolysaccharide), (ii) the levels of proteins responsible for antibiotic resistance, and (iii) the expression of some virulence factors. Our work thus reveals another powerful means used by bacteria to rapidly adapt to a human niche and deal with the threat posed by antimicrobials.
Introduction
Emerging infectious diseases caused by multidrug-resistant bacteria represent a serious threat to human well-being and health. Over the last 40 years, several hundred novel pathologies caused by infectious agents have been reported [1]. Environmental bacteria can adapt to a human host by acquiring virulence traits through chromosomal rearrangements due to the insertion of mobile genetic elements, horizontal gene transfer or small local sequence changes, such as single nucleotide substitutions [2, 3].
The genus Pseudomonas is one of the largest groups of bacteria, found in diverse environments and capable of causing both plant and animal diseases. Pseudomonas species such as P. aeruginosa, P. fluorescens and P. syringae adversely impact human health and agriculture [4–6]. P. aeruginosa is a particularly successful opportunistic pathogen frequently found in humid environments associated with human activities. In hospital settings, infections caused by multidrug-resistant P. aeruginosa strains present a real danger for elderly individuals, patients treated with immunosuppressive therapies and users of invasive devices in intensive care units. In addition to acute infections, P. aeruginosa is a common cause of chronic wound infections, and is linked to long-lasting respiratory infections in patients with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). During chronic infections, the bacteria adjust to their particular host environment by adapting their metabolic pathways and synthesizing particular virulence-associated components [7]. Alterations occurring post-colonization include acquisition of loss-of-function mutations in genes of motility and antibiotic resistance, as well as aggressive factors responsible for acute virulence [8–12].
Recent massive whole-genome sequencing has allowed the classification of clinical and environmental P. aeruginosa strains into four well-defined clades [13, 14]. The different clades rely on different toxins to exert their pathogenic strategies. The two most populated clades inject toxins, also referred to as effectors, ExoS, ExoT, ExoY and ExoU, directly into the host cell cytoplasm using a type-III secretion system (T3SS) [15]. The third and fourth clades are occupied by strains lacking all the genes encoding the effectors and the components of the T3SS. The first fully sequenced taxonomic outlier, PA7, was found to be multi-drug resistant and non-virulent in a mouse model of acute lung infection [16, 17]. Other PA7-related strains were mainly of environmental origin [18, 19], but were occasionally associated with acute (wounds and urinary tract) and chronic (CF and COPD) human infections [20–22]. Some recently emerged highly virulent clones from those clades secrete the pore-forming toxin Exolysin, ExlA, that was found to be responsible for bacterial cytotoxicity [16, 21–24]. The most pathogenic exlA + P. aeruginosa strain described to date is CLJ1, which was isolated at the University Hospital in Grenoble, France, from a COPD patient with haemorrhagic pneumonia [16]. Experimentally infected mice with CLJ1 had extensive damage to their lung endothelial monolayers, and bacteria had transmigrated into the blood and disseminated into secondary organs, all without being detected by the host’s immune system. This clinical scenario differs greatly from the consequences observed with the T3SS+ strain PAO1 [16, 25].
To gain insight into the molecular determinants of pathogenesis expressed by Exolysin-producing P. aeruginosa taxonomic outliers, and to assess the extent of evolutionary adaptation during the course of infection, we performed a comprehensive comparative genome-wide study of two clonal variants, CLJ1 and CLJ3, isolated from the same patient at different time-points during hospitalization. The data gathered demonstrated that mobile genetic elements belonging to the ISL3 insertion sequence (IS) family, originally found in soil bacteria P. stutzeri and P. putida, shaped the virulence traits and strategies used by these strains to colonize their human host, escape from the immune system and resist antibiotic treatment.
Methods
Bacterial strains and culture conditions
The P. aeruginosa strains used in this study were CLJ1 and CLJ3 [16]. Bacteria were grown at 37 °C in liquid Lysogeny broth (LB) medium (per litre: 10 g Bacto tryptone, 5 g yeast extract, 10 g NaCl) with shaking until the cultures reached an optical density of 1.0 (or other value where indicated) at 600 nm (OD600). To assess levels of cyclic-di-GMP (c-di-GMP), pUCP22-pcdrA-gfp(ASV)c was introduced into CLJ1 and CLJ3 strains by electroporation, as previously described [26], and transformed bacteria were selected on LB agar plates containing carbenicillin at 200 µg ml−1.
Genome analysis
Details of sequencing, assembly, annotation and comparison can be found in the Supplementary Materials and Methods. The assembly and annotation statistics for the CLJ1 and CLJ3 genomes are presented in Table S1 (available in the online version of this article). Functional annotation was performed on the Rapid Annotations based on Subsystem Technology (RAST) Genome Annotation Server, version 2.0 [27], using the Classic RAST annotation scheme and the GLIMMER-3 gene caller. Annotations were manually curated based on annotations of orthologous genes in PA7 and PAO1 strains in the Pseudomonas Genome Database [28]. Circos 0.69-3 [29] was used to create the multiomic data visualizations for Figs 1 and S1.
Identifying insertion sites for IS elements
Locations of CLJ-ISL3 insertions in the gaps between CLJ3 contigs were detected by checking for the inverted repeat sequences at contig ends, while taking the shared gene synteny between CLJ1, PA7 and PAO1 genomes into account. PanISa version 0.1.0 (https://github.com/bvalot/panISa) [30] was also used, with default parameters, to search for ISs in CLJ3 reads. Reads were mapped to the PA7 and CLJ1 genomes using the BWA-MEM algorithm from BWA version 0.7.15 [31].
Transcriptome
The RNA for RNA-Seq was prepared as previously described [32] from bacterial cultures grown in duplicate in LB to an OD600 of 1. Briefly, total RNA was isolated using the Direct-zol RNA MiniPrep kit (Zymo). Cells were collected by centrifugation (8000 g, 5 min) and the supernatant was discarded. TRI Reagent (700 µl) was added to the pellet, and bacteria were lysed by vigorous vortexing (2 min). After centrifugation at 13000 g for 1 min, the lysate was transferred to a clean tube containing an equal volume of 100 % ethanol. The ethanol mixture was transferred to a Zymo-Spin IIC Column placed in a collection tube and centrifuged. The column, to which RNAs were bound, was washed according to the manufacturer’s protocol. RNA was finally eluted with 40 µl nuclease-free water. rRNA was depleted using the Ribo-Zero magnetic kit (Epicentre). The Illumina libraries and sequencing were prepared according to standard procedures at the Biopolymer Facility, Harvard Medical School, Boston, USA. Data were analysed as described in the Supplementary Materials and Methods. The total number of reads mapped to the genes was incorporated into a tabular format and analysed as raw counts using the DESeq2 differential expression analysis pipeline. Differentially expressed genes between CLJ1 and CLJ3 were identified using a 5 % false discovery rate (FDR).
MS-based quantitative proteomics analyses
Proteomics samples were prepared and analysed by nano-LC coupled to tandem MS (Ultimate 3000 coupled to an LTQ-Orbitrap Velos Pro; Thermo Scientific) as described previously [33] with slight modifications (see Supplementary Materials and Methods). Each fraction was verified by western blot for purity using appropriate antibodies. The protein content in the whole-cell, membrane and secretome fractions of CLJ1 and CLJ3 was analysed independently. Statistical analyses were performed using ProStaR [34]. In total, a list of 2852 quantified proteins was obtained. The MS proteomics data were deposited with the ProteomeXchange Consortium via the PRIDE [35] partner repository under dataset identifier PXD011105.
Phenotypic analyses
HCN production was assessed on induction plates containing arginine (an HCN precursor), as previously described [22]. Briefly, a sheet impregnated with a Cu2+-containing reaction mixture was placed above agar plates seeded with bacteria. A white-to-blue colour transition indicates HCN production. The fluorescence-based reporter plasmid pUCP22-pCdrA-gfp(ASV)c was used to monitor levels of c-di-GMP [36]. Bacteria carrying the plasmid were subcultured to an OD600 of 0.05 in a black 96-well plate with a clear bottom, and incubated at 37 °C under 60 r.p.m. in the Fluoroskan reader. Fluorescence was measured every 15 min for 6 h, and emission was monitored at 527 nm following excitation at 485 nm. Serum sensitivity was assessed by a protocol adapted from the literature [37]. Two different human sera provided by the French National blood service (EFS) were used in all experiments. Overnight cultures of CLJ1 and CLJ3 bacteria were pelleted at 3000 r.p.m. for 5 min and suspended in Hanks balanced salt solution (HBSS; Gibco) with 0.1 % gelatin, adjusted to 108 c.f.u. ml–1. Bacteria (106) were incubated in the presence of 10 % human serum in a final volume of 3 ml for 15 min or 30 min at 37 °C under gentle agitation. A negative control with heat-inactivated serum (56 °C for 30 min) was included. Numbers of c.f.u. were determined at 0, 15 and 30 min by serial-dilution and spreading on LB plates. Statistical significance was determined using a t-test.
Infections of Galleria mellonella larvae
Calibrated larvae of the wax moth Galleria mellonella were purchased from Sud-Est Appats (http://www.sudestappats.fr). Healthy, uniformly white larvae measuring around 3 cm were selected for infection. The bacteria were grown to an OD600 of 1 and diluted in PBS to approximately 103 bacteria ml–1. Insulin cartridges were sterilized before filling with bacterial solutions. Larvae were injected with 10 µl of bacterial suspensions using an insulin pen. The precise number of bacteria transferred in injections was determined by spotting 10 µl aliquots with the pen five times onto agar plates, and counting c.f.u. after growth at 37 °C for 16 h. Infected larvae were placed in Petri dishes and maintained at 37 °C. Dead larvae were counted over the period indicated. Twenty larvae were used per condition, and the experiment was performed twice.
RT-qPCR
To quantify selected transcripts, total RNA from 2.0 ml cultures (OD600 of 1.0) was extracted with the TRIzol Plus RNA Purification Kit (Invitrogen) and treated with DNase I (Amplification Grade; Invitrogen). Real-time quantitative PCR (RT-qPCR) was performed as described [38] with minor modifications (see Supplementary Materials and Methods). Primer sequences were designed using Primer3Plus (http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi/) and are listed in Table S2. Transcript quantifications are shown with sem.
Statistical analyses
Statistical analyses were performed with ‘T-Test Calculator for 2 Independent Means’ (https://www.socscistatistics.com/tests/studentttest), or a log-rank test. The threshold for statistical significance was set at P<0.05.
Results
Analysis of the CLJ1 genome and its regions of genomic plasticity
CLJ1, an antibiotic-sensitive P. aeruginosa strain, was isolated from a patient with necrotizing haemorrhagic pneumonia. Twelve days after initiating antibiotic therapy, the patient’s condition worsened and a multidrug-resistant clonal variant, CLJ3, was isolated [16]. CLJ1 shares the main genomic features with the first fully sequenced antibiotic-resistant P. aeruginosa taxonomic outlier, PA7 [16, 17]. In particular, CLJ1 lacks the entire locus encoding the T3SS machinery and the genes encoding all known T3SS effectors; however, it carries the determinant for the two-partner secretion pore-forming toxin, Exolysin. To initiate genome-wide studies into the mechanisms conferring the specific CLJ1 phenotypes, we sequenced the genome of this strain and compared it to PA7. As expected, most core genes were shared by the two strains (Figs 1 and S1). However, differences in the content and distribution of several variable regions, or ‘regions of genomic plasticity (RGPs)’ as defined by Mathee et al. [39], were detected. Thus, the CLJ1 genome contained 15 regions that are absent from the PA7 genome, and lacked 26 PA7 regions, including some outside recognizable RGPs (Table S4). The differences between PA7 and CLJ1 are presented in Tables S3 and S4. All CLJ1 regions absent from PA7 (CLJ-SR), except CLJ-SR14, were detected in other P. aeruginosa strains, some of which are phylogenetically unrelated to the PA7 strain. Strikingly, CLJ-SR14 carries 55 genes, including many that are predicted to encode proteins involved in metabolism and resistance to heavy metals (Table S5), suggesting that the strain is of environmental origin. Moreover, the so-called Dit island previously found in a CF isolate of P. aeruginosa [39] was found inserted into the 5′ region of RGP27 at a tRNAGly. The determinants encoded in this island provide the bacteria with the ability to degrade aromatic diterpenes – tricyclic resin acids produced by wounded trees – and to use them as sole carbon and energy source [40]. The Dit island is uncommon in P. aeruginosa strains, but is frequently found in a range of soil bacteria such as Burkholderia xenovorans, P. fluorescens and Pseudomonas mendocina. Identification of this island further supports an environmental origin of the CLJ1 strain. Interestingly, most of the genes within RGP7 (pKLC102-like island) were missing from CLJ1 (Table S4).
Four gene clusters have been defined as replacement islands in P. aeruginosa; they carry horizontally acquired material and sequences diverge significantly between strains [41, 42]. These gene clusters encode proteins involved in the biosynthesis or post-translational modification of lipopolysaccharide (LPS) O antigen, pyoverdine, pili and flagella. Modifications to three of these clusters can produce the CLJ1-specific phenotype. The CLJ replacement island in RGP60 (harbouring pilin and pilin-modification genes) carries a group I pilin allele. In contrast, PA7 contains a group IV allele [43]. Within RGP9, CLJ1 encodes a b-type flagellin as the principal component of its flagellum, while PA7 has an a-type flagellin [17]. RGP9, containing the flagellin glycosylation genes, and the replacement island in RGP31, bearing the O-specific antigen (OSA) biosynthesis gene cluster, were further modified in CLJ strains (see below).
Among other potential virulence-associated genes, CLJ1 lacks one of the three copies of the type-6 secretion system loci (PSPA7_2884–2902) encoding a machine to inject toxins with activity in both prokaryotic and eukaryotic cells [44]. The plcH and plcR genes, coding for the haemolytic phospholipase C precursor and its accessory protein, respectively, were also absent from the CLJ1 genome. Although the cupA fimbrial gene cluster (CLJ1_2899–2903; PSPA7_3019–3023) was present in RGP23, the entire cupE1-6 operon (PSPA7_5297–5302), which encodes cell surface fimbriae required to maintain a biofilm structure [45], was missing.
Evidence of mobile genetic elements in key pathogenic regions
The CLJ3 isolate was sampled from the same patient after a series of aggressive antibiotic treatments and displayed different cytotoxicity and antibiotic-sensitivity profiles compared to CLJ1 [16]. The genomes of the two strains were almost identical, with a reciprocal best-hit average nucleotide identity [46] estimated at 99.97 %, and >600 SNPs between them (Fig. 1). When analysing the genomes of CLJ1 and CLJ3, the most striking feature was the presence of multiple copies of a 2985 bp fragment corresponding to a mobile genetic element, absent from the reference PA7 genome. At the nucleotide level, the whole sequence of this element was 99 % identical to ISPst2 from P. stutzeri, ISpu12 from P. putida and IS1396 from Serratia marcescens, found in the ISfinder database [47] (Table S6). Further examination of publicly available genome sequences (NCBI release February 2019) by blastn searching revealed the fragment to be 100 % identical to a part of the pU12A_D plasmid present in the Escherichia coli ST131 urinary tract isolate (accession number: PRJNA516746). The complete sequence was also detected in a few other bacterial strains, including a multi-drug-resistant Acinetobacter baumannii isolate recovered from bronchoalveolar lavage fluid [48]. The element is an isoform of ISPst2 and belongs to the ISL3 family, and we therefore named it CLJ-ISL3. In addition to coding for a transposase, CLJ-ISL3 encodes a putative seven-transmembrane domain inner-membrane protein (344 aa, 36 kDa) from the permease superfamily cl17795 (with the conserved domain COG0701 [49]) and a putative transcriptional metalloregulator from the ArsR family (Fig. 2a). The element is flanked by a pair of 24 bp imperfect inverted repeat sequences, GGGTATCCGGAATTTCTGGTTGAT (left inverted repeat, IRL) and GGGTATACGGATTTAATGGTTGAT (right inverted repeat, IRR) (Fig. 2a).
Six and 40 copies of CLJ-ISL3 were present in the genomes of CLJ1 and CLJ3, respectively. The six insertions in the CLJ1 genome were revealed by blast mining of the assembled contigs. In the CLJ3 genome, most of the ISs were predicted using a combination of bioinformatics tools, analysis of genome synteny and detection of inverted sequences (Materials and Methods). In agreement with the clonal origin of the strains, all but one of the CLJ-ISL3 in CLJ1 were found in the same location in the CLJ3 genome (Fig. 1, Table S7). MS-based quantitative proteomic analyses revealed a strong increase in expression of the transposase protein in CLJ3 compared to CLJ1, which might be the result of the considerably higher number of ISs within its genome (Table S8). As mobile genetic elements contribute significantly to phenotypic modifications by altering gene expression or by inactivating genes [50, 51], we examined how these insertions affected overall gene expression and specific phenotypes. To do so, we compared CLJ1 and CLJ3 transcriptomes and proteomes using RNA-Seq and MS-based quantitative proteomics, respectively. The proteomes for three different bacterial fractions (whole bacteria, total membranes and secretomes) were analysed. Stringent statistical analyses of extracted data revealed 75 differentially expressed elements between CLJ1 and CLJ3, at both mRNA and protein levels (Fig. 1, Tables S8, S9 and S10). Among these elements, 27 (35 %) were phage-related, while 32 (42 %) were predicted to be localized in bacterial membranes, the periplasm or secreted.
Contribution of CLJ-ISL3 to antibiotic resistance in the CLJ3 strain
The CLJ1 and CLJ3 strains were recently isolated from a patient treated unsuccessfully with high doses of various antibiotics. CLJ1, isolated before the beginning of the antibiotic therapy, was sensitive to the antibiotics tested, whereas CLJ3 displayed resistance to most of the antibiotics administered to the patient [16]. To gain insights into the mechanisms of antibiotic resistance developed by CLJ3, we examined the genomic data for gene modifications that could explain the switch in phenotypes. Several genes encoding proteins potentially conferring antibiotic resistance were observed to be modified by ISs.
As the patient was given several antibiotics from the β-lactam family (ticarcillin, carbapenem, cephalosporin, etc.) and the CLJ3 isolate developed resistance to all of them, we examined the status of the two major determinants of intrinsic resistance to this group of antibiotics, the outer-membrane porin OprD (CLJ1_4366) and the chromosomally encoded AmpC β-lactamase (CLJ1_0728). The oprD gene was found to be interrupted by the CLJ-ISL3 insertion (Fig. 2b), resulting in absence of the protein (Table S8). Loss-of-function mutations or deletions in oprD make the cell envelope impermeable to these antibiotics and have been repeatedly reported in isolates from patients undergoing treatment with imipenem or meropenem [52–55]. In addition, CLJ-ISL3 was detected in the 5′ portion of the ampD gene (Fig. 2c), encoding the recycling amidase responsible for the production of muropeptide regulators of ampC expression [56, 57]. Consequently, although RNA-Seq data indicated no difference in ampC expression, CLJ3 proteomes contained significantly greater amounts of the AmpC protein than CLJ1 extracts (Table S8).
Two additional periplasmic proteins involved in peptidoglycan recycling and biosynthesis, the AmpDH3 amidase (CLJ1_5671) [58] and the lytic transglycosylase MltA-interacting protein MipA (CLJ1_3357) [59], were also over-represented in the CLJ3 proteome. In these cases, RT-qPCR data indicated that the corresponding genes were also overexpressed (Fig. 2d, Table S9). Overproduction of these proteins in a clinical strain suggests a role in adaptation of the strain to the host through modulation of peptidoglycan synthesis. However, we were unable to find a link between upregulation of those two genes and CLJ-ISL3 insertion. The molecular mechanisms involved in the increased expression observed and the relevance of their overexpression to bacterial persistence in the host therefore remain to be determined.
All P. aeruginosa strains carry genes for multiple efflux pumps. The CLJ1/PA7 clade possesses the locus encoding the MexXY-OprA efflux pump, which can transport multiple antibiotics including fluoroquinolones, aminoglycosides and certain cephalosporins (reviewed by Li and colleagues [60]). However, when compared to CLJ1, an approximately 20 kb deletion in the CLJ3 genome (resulting in loss of 22 genes corresponding to PSPA7_3247–3268) was detected, corresponding to elimination of the entire transcriptional repressor mexZ gene and truncation of mexX (Fig. 2e). The deleted region was replaced by a copy of CLJ-ISL3 that is bordered by truncated puuP and mexX sequences. One plausible explanation for the genomic arrangement observed in this region in CLJ3 is that the strain was derived from an as-yet unidentified clonal strain that had another copy of CLJ-ISL3 in mexX. Recombination between these two IS elements would produce the 20 kb deletion, simultaneously eliminating the repressor and a portion of the mexX genes, rendering this efflux pump non-functional. To investigate this hypothesis, we analysed the DR (direct repeat) sequences flanking the CLJ-ISL3 sequences in both CLJ1 and CLJ3 genomes. DRs are short sequences generated during the process of IS insertion, and their analysis can provide evidence of homologous recombination between two IS elements. CLJ-ISL3 inserted in the CLJ1 puuP gene was flanked by the 8-bp-long ‘TTCTTTTT’ sequence, corresponding to the classical DR length for ISL3. In agreement with our hypothesis, a hybrid element was found in CLJ3, as the same DR sequence was found to flank one side of the IS (in the puuP truncated gene), whereas the sequence 'AATTTTTC' of mexX was found on the other side. Truncation of the puuP gene, encoding putrescine importer/permease, indicates that the CLJ-ISL3 sequence affects transport of polyamines, which play multiple roles in pathogen biology, including conferring resistance to some antibacterial agents [61].
Modifications to the OSA cluster due to CLJ-ISL3 insertions
OSA is a component of LPS and an integral component of the cell envelope of P. aeruginosa. The OSA biosynthetic gene cluster in CLJ, RGP31, is similar in content to that of PA7, and both PA7 and CLJ1 belong to serotype O12 [22]. However, insertion of two different ISs affects the gene content and expression levels of the proteins encoded (Fig. 3a). In CLJ1, the CLJ-ISL3 element was detected within the gene encoding NAD-dependent epimerase/dehydratase (CLJ1_1762 corresponding to PSPA7_1970), whereas in CLJ3 two copies were present, one disrupting wbjL and the second located in the intergenic region between CLJ3_1919 and CLJ3_1920 (PSPA7_1972). In addition, in CLJ3, two copies of another IS, sharing 75 % nucleotide identity with ISCARN15 from the IS66 family, were detected within the wbjB gene (CLJ1_1771; CLJ3_1930), and downstream of wbjM (CLJ1_1778; CLJ3_1936). By performing bioinformatic searches for IS extremities in CLJ1 and CLJ3 contigs, this IS, which we named CLJ-IS66, was found to be present in a single location in CLJ1, within the CLJ-SR12 region (CLJ_4873-CLJ_4876). An identical insertion was found in CLJ3. CLJ-IS66 within the OSA locus negatively affects expression of the corresponding genes, or stability of the mRNA produced, as higher levels of both mRNA and protein were detected in CLJ1 compared to CLJ3 (Tables S8 and S9).
Interestingly, the deletion at the mexX-puuP locus in CLJ3 described above also encompasses the galU gene (CLJ1_3121, Fig. 2e), which encodes UDP glucose pyrophosphorylase [62]. This enzyme adds sugar moieties onto the inner core on lipid A, serving as an anchor for the full-length LPS. In the absence of galU, LPS is truncated and a rough LPS is produced, making bacteria more susceptible to serum-mediated killing and reducing their in vivo virulence [63]. The CLJ3 strain was indeed more sensitive to serum than the CLJ1 strain (Fig. 3b). The in vivo mechanism leading to selection of a serum-sensitive phenotype is unclear. Modification to LPS structures in P. aeruginosa strains chronically infecting CF patients is considered an adaptation mechanism to a more ‘persistent’ lifestyle, by making the LPS molecule less inflammatory [63]. Thus, multiple mechanisms contributed to the final LPS structure in CLJ clones. Those events could have provided strains with numerous advantages during the infection process, such as resistance to antimicrobials or altered recognition by the immune system.
ISs determine the repertoire of surface appendices
Inspection of CLJ1 and CLJ3 genome sequences showed that CLJ-ISL3 has strongly affected the flagellar biosynthetic locus in both strains. The CLJ3 genome revealed an organization and gene content of the flagellar locus similar to that found in PAO1, which synthesizes a b-type flagellum [64], but with two copies of CLJ-ISL3 (Fig. 4a). The first IS interrupts flgL (CLJ1_4222), encoding the flagellar hook-associated protein through which the flagellum tethers to the cell envelope, whereas the second IS element is in fgtA (CLJ1_4219), which codes for the flagellin glycosyl transferase. These two ISs seem to have recombined in CLJ1, creating a deletion between the truncated fgtA and flgL genes (Fig. 4a). In agreement, the DRs flanking the two sides of the CLJ-ISL3 in CLJ1 are different and correspond to that found in CLJ3 in the IS integrated within fgtA (‘ATTTTCCA’) and flgL (‘CGAAAATA’). This recombination between two ISs suggests that CLJ1 is not the direct ancestor of CLJ3, but that the two strains evolved from a common ancestor. The absence of a flagellum is in agreement with the non-motile phenotype of the strain observed during eukaryotic cell infection and on soft agar [22]. Bacterial flagella are also known to modulate the immune response during the response to infection, through binding of the major flagellar subunit, flagellin, to TLR5, which triggers TLR-dependent signalling and activates expression of pro-inflammatory cytokines [65]. The absence of assembled flagella in the isolates explains why pro-inflammatory cytokine IL-1β and tumour necrosis factor were undetectable in bronchoalveolar lavages from CLJ1-infected mice [23, 25].
As CLJ1 also lacks twitching motility [22], we examined the genomic data for possible mutations in genes encoding type IV pili (T4P) and found an insertion of CLJ-ISL3 within the 5′ part of the pilM gene in both the CLJ1 and the CLJ3 genomes (Fig. 4b). This gene encodes a cytoplasmic actin-like protein, and is the first gene in the pilMNOPQ operon, which is reported to be essential for both T4P biogenesis and twitching motility [66]. Expression of the entire operon appears to be affected, as no proteins were detected by proteomic analysis, unlike several other Pil proteins encoded by other operons (Table S8). This effect is probably due to the polar effect of the IS element on the downstream genes. This finding was intriguing as the action of Exolysin, responsible for CLJ1 cytotoxicity, relies heavily on T4P in another exlA + strain, IHMA87 [67]. Therefore, we examined CLJ1 proteomes for the presence of other putative adhesive molecules that may substitute for the T4P function during host cell invasion. Based on proteomic datasets, the CLJ1 strain synthesizes components of five two-partner secretion (TPS) systems, the predicted secreted components, some of which are annotated as haemolysins/haemagglutinins, including Exolysin (CLJ1_4479). As expected, Exolysin (ExlA) was found to be more abundant in the secretome produced by CLJ1 than in the secretome from CLJ3 (log2FC −1.7, P=8.24E-02) (Table S8). CdrA and CdrB (CLJ1_4999 and CLJ1_5000) were significantly overrepresented in the CLJ3 strain according to proteomics and RNA-Seq analyses (Tables S8 and S9). In the PAO1 strain, the adhesin CdrA is regulated by the secondary messenger c-di-GMP, and its expression increases in biofilm-growing conditions [68]. In the strains studied here, we assessed the cellular levels of c-di-GMP using a reporter based on the c-di-GMP-responsive cdrA promoter transcriptionally fused to a gene encoding unstable GFP [36]. The pcdrA-gfp(ASV)C monitoring plasmid clearly revealed higher levels of the second messenger in CLJ3 during growth (Fig. 4c), suggesting that CLJ3 may have adapted to host conditions by switching to the biofilm lifestyle. Another TpsA protein detected in CLJ secretomes is CLJ1_4560, an HMW-like adhesin named PdtA in the PAO1 strain. PdtA plays a role in P. aeruginosa virulence, as demonstrated in the Caenorhabditis elegans model of infection [69]. The production of five TPSs, including the protease LepA (CLJ1_4911) [70] and at least one contact-dependent inhibition protein Cdi (CLJ1_2745) [71, 72], in CLJ strains (Table S8) indicates that this family of proteins may play an important role during colonization and infection, but their respective contributions to adhesion, cytotoxicity or inter-bacterial competition during the infectious process will need to be investigated.
Other putative virulence factors, phages and metabolism
RNA-Seq results, supported by proteomics data, showed increased expression of the enzymes HcnB (CLJ1_2955) and HcnC (CLJ1_2954) in the CLJ1 strain (Table S10). Inspection of the hcn operon revealed that the CLJ-ISL3 element was inserted into the 5′ part of the hcnB gene in the CLJ3 genome (Fig. 5a), which explains the lack of expression measured by RT-qPCR (Fig. 5b). The hcn genes encode the subunits of hydrogen cyanide (HCN) synthase, which produce a toxic secondary metabolite [73]. The HCN produced by the strains was detected using a standard method (see Material and Methods). In agreement with proteomics data, CLJ1 produced HCN in higher quantities than CLJ3 (Fig. 5b, [22]). Many P. aeruginosa isolates from individuals with CF produce high levels of HCN [74], and the molecule has even been detected in the sputum of P. aeruginosa-infected CF and bronchiectasis patients [75, 76]. HCN also plays a regulatory role, inducing and repressing the expression of other genes [77], including the PA4129-PA4134 gene cluster in PAO1. This seven-gene cluster (CLJ1_0701-CLJ1_0702, CLJ1_0704-CLJ1_0708) is expressed at higher levels in CLJ1 compared to CLJ3 (Fig. 1, Tables S8 and S9). These results were confirmed for ccoG2 and ccoN4 by RT-qPCR (Fig. 5c). ccoG2 codes for a cytochrome c oxidase accessory protein and ccoN4 for a cytochrome c oxidase subunit, both products being involved in aerobic respiration. The ccoN4 gene belongs to the ccoN4Q4 operon, one of the two ccoNQ orphan gene clusters present in the P. aeruginosa genome. Its upregulation in the cyanogenic CLJ1 is in agreement with a study showing that, although P. aeruginosa encodes a cyanide-insensitive oxidase CIO, isoforms of cbb3-type cytochrome c oxidase containing the CcoN4 subunit were produced in response to cyanide, exhibiting higher tolerance towards this poisonous molecule in low-oxygen conditions [78]. Among the other genes in the cluster are found a putative sulfite reductase-encoding gene (CLJ1_0707) and a gene (CLJ1_0708) coding for an oxidoreductase probably involved in sulfite reduction; however, their exact role is unknown.
Examining the data for differential expression of putative virulence determinants indicated that CLJ3 overproduces Lipotoxin F (LptF, CLJ1_1186), an outer-membrane protein contributing to adhesion to epithelial A549 cells which is known to activate the host inflammatory response [79]. The lptF gene is located in a putative operon together with a gene encoding a hypothetical protein predicted to be a lipoprotein located in the periplasm (CLJ1_1187). Proteomics analysis revealed this hypothetical protein to be upregulated in CLJ3 (Table S8). As lptF upregulation was not detected by initial RNA-Seq analysis, we performed RT-qPCR assays. Significant overexpression of both lptF and CLJ1_1187/CLJ3_1413 was detected in CLJ3 (Fig. 5c), suggesting that Lipotoxin F together with CLJ1_1187 contributed to bacterial adaptation to in-human environments, in line with increased lptF expression in CF isolates [80].
Finally, prophages play important roles in P. aeruginosa physiology, adaptation and virulence [41, 81, 82]. In the CLJ genomes, at least eight regions related to phages were identified (Table S11), five of which differ or are absent from the PA7 genome (Table S3). Transcriptomic and proteomic approaches revealed 27 phage-related proteins from CLJ1_0539–0556 in RGP3 and CLJ1_4296–4314, including CLJ-SR11, to be significantly more abundant in CLJ3 compared to CLJ1 extracts (Tables S8–S10). Interestingly, both CLJ strains lacked the genes encoding bacteriocins, in particular pyocins S2, S4, and S5. Nevertheless, a homologue of PrtN (CLJ1_0535), an activator of pyocin biosynthetic genes [83], was expressed at higher levels in CLJ3 than in CLJ1. Indeed, the prtN gene is located in a region encoding phage-related proteins, all of which are overexpressed in CLJ3 (Fig. 1 and Table S10). The genes for AlpR (CLJ1_4295, CLJ3_4269) and AlpA (CLJ1_4296, CLJ3_4268), transcriptional regulators of a programmed cell death pathway in PAO1 [84], were also identified in both CLJ genomes. Finally, alpA and all the genes in the alpBCDE lysis cassette were highly expressed in CLJ3 (Fig. 1 and Table S10). The alp genes are present in a variable, phage-related region that differs in gene composition from PAO1 and PA7 strains, but is identical to that found in three recently sequenced exlA + isolates: AR441 (GenBank: CP029093.1), AR_0356 (GenBank: CP027169.1) and CR1 (GenBank: CP020560.1).
CLJ-ISL3 inactivates the imu operon encoding translesion synthesis machinery
Another location of the CLJ-ISL3 element in the CLJ1 and CLJ3 genomes was within the imu operon, also known as the mutagenesis cassette (Fig. 5d). The imu operon encodes the ImuC polymerase (formerly DnaE2) and other components of translesion synthesis (TLS), which can bypass lesions caused by DNA damage. The ImuC polymerase in Pseudomonas contributes to tolerance to DNA alkylation agents [85], and inactivation of the operon could limit the accumulation of mutations. Interestingly, P. aeruginosa isolates from patients with CF frequently display a hyper-mutator phenotype, primarily linked to inactivation of mutS. This phenotype has previously been suggested to be advantageous for bacterial adaptation to the niche in CF lungs [86]. The mutS gene was identical and intact in CLJ1 and CLJ3, and the predicted proteins differed from the MutS in PA7 by a single amino acid at position 593 (threonine in PA7, serine in CLJ1/CLJ3). Consequently, the physiological impact of inactivation of the TLS system is unclear. Two additional DNA-repair proteins, RecN (CLJ1_5150) and RecA (CLJ1_1263), were over-represented in CLJ3 at both the transcriptome and the proteome levels (Table S10), suggesting an interplay between different mechanisms to defend against uncontrolled mutational rates induced by a hostile environment. More than 600 SNPs were found between CLJ1 and CLJ3, a rate about six times higher than that recorded for sequential isolates in the same CF patients over 8.8 years in one study [10] and almost ten times higher than the mutations reported in a matched isolate pair, collected from a single patient with a 7.5-year interval in another study [12]. However, yet another study indicated that some strains isolated from non-CF patients could have between 176 and 736 SNPs [9]. Although we could not precisely account for the role of the SNPs detected, they may contribute to differences in gene expression between the two isolates that could not be directly attributed to ISs.
The two CLJ clones show different pathogenic potential in G. mellonella
To assess the overall virulence of the two strains in a whole organism, we used the wax moth (Galleria) infection model, and monitored the survival of infected larvae following inoculation with the different strains. Under the same infection conditions, the CLJ1 strain was found to be more virulent than the PA7 strain, and CLJ3 was unable to kill Galleria larvae (Fig. 5e). This result indicates that CLJ3, in the process of gaining resistance to antimicrobials, lost its virulence potential, a finding that agrees with our previous observation that CLJ3 is sensitive to serum (Fig. 3b) and less cytotoxic due to loss of its ability to secrete Exolysin [16]. More than 40 CLJ-ISL3 ISs were detected in the CLJ3 genome, some within or upstream of genes encoding hypothetical proteins or putative regulators (Table S7), and some of which may have influenced fitness of the CLJ3 strain in the Galleria model of infection. Thus, we found that ISs contributed significantly to the pathogenicity of the CLJ1 strain and to the multi-drug resistance of CLJ3. As the two isolates may have coexisted in the patient’s lungs, we can conclude that ISs determined the overall success of the CLJ lineage in establishing lethal infection.
Discussion
P. aeruginosa strains from the group of taxonomic outliers are abundant in humid environments [18, 19, 87, 88] and, based on a previous study, are considered to be innocuous [89]. Here, we present the results of a multiomics approach applied to two recent clinical isolates, CLJ1 and CLJ3, members of the same group of taxonomic outliers. The results provided insights into genome-wide modifications that provided these bacteria with the tools to successfully colonize and disseminate within the human host. We found the genomes of both strains to be highly dynamic and to evolve within the patient due to high numbers of ISs. General pathogenic and survival traits, e.g. motility, adhesion and resistance to antimicrobials, were modulated by the CLJ-ISL3 element. The later isolate, CLJ3, had acquired resistance toward antibiotics with which the patient was treated during hospitalization, and some ISs directly affected components involved in resistance. Compared to the early colonizer CLJ1, the CLJ3 strain also displayed higher intracellular levels of c-di-GMP, higher expression of the biofilm-associated adhesion protein CdrA, and had lost part of its LPS due to deletion of the galU gene. All these features promoted adaptation to a lifestyle associated with chronic infection. Moreover, by bioinformatics screening we identified 36 additional IS elements in the CLJ3 genome, and these probably contributed to other phenotypic changes which were not assessed in this study. In addition to previously known virulence determinants, several of the genes that were differentially expressed here were annotated as ‘hypothetical’ by RAST automated annotation technology. Their contribution to P. aeruginosa’s adaptation to life within a human host should now be further explored.
Although the precise origin of the CLJ-ISL3 identified in the CLJ lineage is unknown, we speculate that it was acquired from another bacterial species present in the environment. Indeed, the GC content of the CLJ1-ISL3 sequence is 54.8 %, whereas in the rest of the P. aeruginosa genome it is 66.6 %, suggesting recent acquisition by horizontal transfer. Initial disruption of the genes encoding flagellar components and pili by this sequence may have allowed the CLJ strain to evade the patient’s immune defences. By increasing its capacity to secrete the pore-forming toxin Exolysin, the strain acquired an additional advantage allowing it to further damage the host epithelium and endothelial tissues to promote its dissemination.
Previous studies have indicated that the contribution of ISs to the adaptation of P. aeruginosa to the environment in patients with CF is low, with limited numbers of transposition events occurring during chronic infection [90]. This finding contrasts with reports on in vitro evolution experiments with E. coli [91, 92]. A search of the Pseudomonas database [28] with the nucleotide sequence of the CLJ1-ISL3 fragment revealed a total of 12 strains bearing 100 % identical fragments. Eight of these strains were isolated at Copenhagen University Hospital [93], and the four others in a Seattle-based hospital intensive care units [94]. The precise positions of CLJ-ISL3 in those genomes and the phenotypes produced by the disrupted gene(s) are currently unknown, but this knowledge could provide insights into whether and how the CLJ-ISL3 sequence contributes to the colonization process and the adaptation of those strains to a particular infectious niche. More recent genomic characterization of environmental P. aeruginosa isolates from dental unit waterlines showed that, in addition to the OSA loci, ISPa11 altered the genes for two master regulators, LasR and GacS, supporting the idea of a potential for ecological adaptation of P. aeruginosa through the integration of mobile elements [95]. Thus, in addition to small nucleotide changes in pathoadaptive genes, mobile genetic elements could drive the emergence of phenotypic traits allowing P. aeruginosa to adapt to the niche they encounter, and undoubtedly contribute to strain-specific pathogenicity. The overall contribution of ISs to the increase in the bacterial pathogenic arsenal is quite likely to be underestimated as we currently have limited access to closed bacterial genomes. New DNA sequencing technologies accessing genome fragments measuring tens or even hundreds of kilobases should shed light on the overall impact of mobile elements throughout bacterial evolution.
Supplementary Data
Funding information
This work was supported by grants from the French National Research Agency (ANR-15-CE11-0018-01), the Laboratory of Excellence GRAL (ANR-10-LABX-49–01) and the Fondation pour la Recherche Médicale (Team FRM 2017, DEQ20170336705). Proteomics experiments were partly supported by the Proteomics French Infrastructure (ANR-10-INBS-08–01). We further acknowledge support from CNRS, INSERM, CEA and University Grenoble Alpes. Work in S.L.’s laboratory was supported by a grant from the Cystic Fibrosis Foundation. A.B.’s PhD research was funded by a fellowship from the CEA Irtelis programme. The funding bodies played no part in the design of the study, the collection, analysis or interpretation of data or in writing the manuscript. Funding for open access charges: French National Research Agency (ANR-15-CE11-0018-01).
Acknowledgements
The authors thank Maria Guillermina Casabona for early proteomics experiments on CLJ strains, and Yves Vandenbrouck (CEA, Grenoble), Frédéric Boyer (UGA, Grenoble) and François Lebreton (HMS, Boston) for advice on genome analysis. We express our particular thanks to Mylène Robert-Genthon and Florian Chenavier for RT-qPCR and PCR experiments and to Peter Panchev for performing the Galleria infection assays. We are grateful to Tim Tolker-Nielsen for the gift of the pUCP22-pcdrA-gfp(ASV)c plasmid.
Author contributions
E. S. performed all the bioinformatics analyses of the data presented in this paper. P. B., A. B., G. B., Y. C. and A. A. performed experiments. S. L. provided materials. S. E. and I. A. designed the study and performed experiments. Y. C., S. E. and I. A. analysed the data. S. E. and I. A. wrote the manuscript. All authors participated in figure and table preparation and revision of the final version of the manuscript.
Conflicts of interest
The authors declare that there are no conflicts of interest.
Footnotes
Abbreviations: CF, cystic fibrosis; COPD, chronic obstructive pulmonary disease; DR, direct repeat; IS, insertion sequence; FDR, false discovery rate; LPS, lipopolysaccharide; OSA, O-specific antigen; RGP, region of genomic plasticity; T3SS, type 3 secretion system; T4P, type IV pili; TLS, translesion synthesis; TPS, two-partner secretion.
All supporting data, code and protocols have been provided within the article or through supplementary data files. One supplementary figure and eleven supplementary tables are available with the online version of this article.
References
- 1.Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, et al. Global trends in emerging infectious diseases. Nature. 2008;451:990–993. doi: 10.1038/nature06536. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bartoli C, Roux F, Lamichhane JR. Molecular mechanisms underlying the emergence of bacterial pathogens: an ecological perspective. Mol Plant Pathol. 2016;17:303–310. doi: 10.1111/mpp.12284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Diard M, Hardt WD. Evolution of bacterial virulence. FEMS Microbiol Rev. 2017;41:679–697. doi: 10.1093/femsre/fux023. [DOI] [PubMed] [Google Scholar]
- 4.Aujoulat F, Roger F, Bourdier A, Lotthé A, Lamy B, et al. From environment to man: genome evolution and adaptation of human opportunistic bacterial pathogens. Genes. 2012;3:191–232. doi: 10.3390/genes3020191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Silby MW, Winstanley C, Godfrey SA, Levy SB, Jackson RW. Pseudomonas genomes: diverse and adaptable. FEMS Microbiol Rev. 2011;35:652–680. doi: 10.1111/j.1574-6976.2011.00269.x. [DOI] [PubMed] [Google Scholar]
- 6.Xin XF, Kvitko B, He SY. Pseudomonas syringae: what it takes to be a pathogen. Nat Rev Microbiol. 2018;16:316–328. doi: 10.1038/nrmicro.2018.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Cullen L, McClean S. Bacterial adaptation during chronic respiratory infections. Pathogens. 2015;4:66–89. doi: 10.3390/pathogens4010066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Folkesson A, Jelsbak L, Yang L, Johansen HK, Ciofu O, et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective. Nat Rev Microbiol. 2012;10:841–851. doi: 10.1038/nrmicro2907. [DOI] [PubMed] [Google Scholar]
- 9.Hilliam Y, Moore MP, Lamont IL, Bilton D, Haworth CS, et al. Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung. Eur Respir J. 2017;49:1602108. doi: 10.1183/13993003.02108-2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Marvig RL, Damkiær S, Khademi SM, Markussen TM, Molin S, et al. Within-host evolution of Pseudomonas aeruginosa reveals adaptation toward iron acquisition from hemoglobin. mBio. 2014;5:e00966. doi: 10.1128/mBio.00966-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Marvig RL, Johansen HK, Molin S, Jelsbak L. Genome analysis of a transmissible lineage of Pseudomonas aeruginosa reveals pathoadaptive mutations and distinct evolutionary paths of hypermutators. PLoS Genet. 2013;9:e1003741. doi: 10.1371/journal.pgen.1003741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. PNAS USA. 2006;103:8487–8492. doi: 10.1073/pnas.0602138103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Kos VN, Déraspe M, McLaughlin RE, Whiteaker JD, Roy PH, et al. The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility. Antimicrob Agents Chemother. 2015;59:427–436. doi: 10.1128/AAC.03954-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Thrane SW, Taylor VL, Freschi L, Kukavica-Ibrulj I, Boyle B, et al. The widespread multidrug-resistant serotype O12 Pseudomonas aeruginosa clone emerged through concomitant horizontal transfer of serotype antigen and antibiotic resistance gene clusters. mBio. 2015;6:e01396. doi: 10.1128/mBio.01396-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hauser AR. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol. 2009;7:654–665. doi: 10.1038/nrmicro2199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Elsen S, Huber P, Bouillot S, Couté Y, Fournier P, et al. A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia. Cell Host Microbe. 2014;15:164–176. doi: 10.1016/j.chom.2014.01.003. [DOI] [PubMed] [Google Scholar]
- 17.Roy PH, Tetu SG, Larouche A, Elbourne L, Tremblay S, et al. Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. PLoS One. 2010;5:e8842. doi: 10.1371/journal.pone.0008842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Selezska K, Kazmierczak M, Müsken M, Garbe J, Schobert M, et al. Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure. Environ Microbiol. 2012;14:1952–1967. doi: 10.1111/j.1462-2920.2012.02719.x. [DOI] [PubMed] [Google Scholar]
- 19.Wiehlmann L, Cramer N, Tümmler B. Habitat-associated skew of clone abundance in the Pseudomonas aeruginosa population. Environ Microbiol Rep. 2015;7:955–960. doi: 10.1111/1758-2229.12340. [DOI] [PubMed] [Google Scholar]
- 20.Huber P, Basso P, Reboud E, Attrée I. Pseudomonas aeruginosa renews its virulence factors. Environ Microbiol Rep. 2016;8:564–571. doi: 10.1111/1758-2229.12443. [DOI] [PubMed] [Google Scholar]
- 21.Reboud E, Basso P, Maillard AP, Huber P, Attrée I. Exolysin shapes the virulence of Pseudomonas aeruginosa clonal outliers. Toxins. 2017;9:364. doi: 10.3390/toxins9110364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Reboud E, Elsen S, Bouillot S, Golovkine G, Basso P, et al. Phenotype and toxicity of the recently discovered exlA-positive Pseudomonas aeruginosa strains collected worldwide. Environ Microbiol. 2016;18:3425–3439. doi: 10.1111/1462-2920.13262. [DOI] [PubMed] [Google Scholar]
- 23.Basso P, Wallet P, Elsen S, Soleilhac E, Henry T, et al. Multiple Pseudomonas species secrete exolysin-like toxins and provoke Caspase-1-dependent macrophage death. Environ Microbiol. 2017;19:4045–4064. doi: 10.1111/1462-2920.13841. [DOI] [PubMed] [Google Scholar]
- 24.Huber P, Basso P, Reboud E, Attrée I. Pseudomonas aeruginosa renews its virulence factors. Environ Microbiol Rep. 2016;8:564–571. doi: 10.1111/1758-2229.12443. [DOI] [PubMed] [Google Scholar]
- 25.Bouillot S, Munro P, Gallet B, Reboud E, Cretin F, et al. Pseudomonas aeruginosa Exolysin promotes bacterial growth in lungs, alveolar damage and bacterial dissemination. Sci Rep. 2017;7:2120. doi: 10.1038/s41598-017-02349-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Choi KH, Kumar A, Schweizer HP. A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation. J Microbiol Methods. 2006;64:391–397. doi: 10.1016/j.mimet.2005.06.001. [DOI] [PubMed] [Google Scholar]
- 27.Aziz RK, Bartels D, Best AA, Dejongh M, Disz T, et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics. 2008;9:75. doi: 10.1186/1471-2164-9-75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Winsor GL, Griffiths EJ, Lo R, Dhillon BK, Shay JA, et al. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database. Nucleic Acids Res. 2016;44:D646–D653. doi: 10.1093/nar/gkv1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19:1639–1645. doi: 10.1101/gr.092759.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Treepong P, Guyeux C, Meunier A, Couchoud C, Hocquet D, et al. panISa: ab initio detection of insertion sequences in bacterial genomes from short read sequence data. Bioinformatics. 2018;34:3795-3800. doi: 10.1093/bioinformatics/bty479. [DOI] [PubMed] [Google Scholar]
- 31.Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv. 2013:1303.3997 [Google Scholar]
- 32.Han K, Tjaden B, Lory S. GRIL-seq provides a method for identifying direct targets of bacterial small regulatory RNA by in vivo proximity ligation. Nat Microbiol. 2017;2:16239. doi: 10.1038/nmicrobiol.2016.239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Casabona MG, Vandenbrouck Y, Attree I, Couté Y. Proteomic characterization of Pseudomonas aeruginosa PAO1 inner membrane. Proteomics. 2013;13:2419–2423. doi: 10.1002/pmic.201200565. [DOI] [PubMed] [Google Scholar]
- 34.Wieczorek S, Combes F, Lazar C, Giai Gianetto Q, Gatto L, et al. DAPAR & ProStaR: software to perform statistical analyses in quantitative discovery proteomics. Bioinformatics. 2017;33:135–136. doi: 10.1093/bioinformatics/btw580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Vizcaíno JA, Csordas A, del-Toro N, Dianes JA, Griss J, et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 2016;44:D447–D456. doi: 10.1093/nar/gkv1145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Rybtke MT, Borlee BR, Murakami K, Irie Y, Hentzer M, et al. Fluorescence-based reporter for gauging cyclic di-GMP levels in Pseudomonas aeruginosa . Appl Environ Microbiol. 2012;78:5060–5069. doi: 10.1128/AEM.00414-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Zlosnik JE, Gunaratnam LC, Speert DP. Serum susceptibility in clinical isolates of Burkholderia cepacia complex bacteria: development of a growth-based assay for high throughput determination. Front Cell Infect Microbiol. 2012;2:67. doi: 10.3389/fcimb.2012.00067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Berry A, Han K, Trouillon J, Robert-Genthon M, Ragno M, et al. cAMP and Vfr Control Exolysin Expression and Cytotoxicity of Pseudomonas aeruginosa Taxonomic Outliers. J Bacteriol. 2018;200 doi: 10.1128/JB.00135-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, et al. Dynamics of Pseudomonas aeruginosa genome evolution. PNAS USA. 2008;105:3100–3105. doi: 10.1073/pnas.0711982105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Smith DJ, Park J, Tiedje JM, Mohn WW. A large gene cluster in Burkholderia xenovorans encoding abietane diterpenoid catabolism. J Bacteriol. 2007;189:6195–6204. doi: 10.1128/JB.00179-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kung VL, Ozer EA, Hauser AR. The accessory genome of Pseudomonas aeruginosa . Microbiol Mol Biol Rev. 2010;74:621–641. doi: 10.1128/MMBR.00027-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Klockgether J, Cramer N, Wiehlmann L, Davenport CF, Tümmler B. Pseudomonas aeruginosa Genomic Structure and Diversity. Front Microbiol. 2011;2:150. doi: 10.3389/fmicb.2011.00150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Kus JV, Tullis E, Cvitkovitch DG, Burrows LL. Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology. 2004;150:1315–1326. doi: 10.1099/mic.0.26822-0. [DOI] [PubMed] [Google Scholar]
- 44.Sana TG, Berni B, Bleves S. The T6SSs of Pseudomonas aeruginosa Strain PAO1 and Their Effectors: Beyond Bacterial-Cell Targeting. Front Cell Infect Microbiol. 2016;6:61. doi: 10.3389/fcimb.2016.00061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Giraud C, Bernard CS, Calderon V, Yang L, Filloux A, et al. The PprA-PprB two-component system activates CupE, the first non-archetypal Pseudomonas aeruginosa chaperone-usher pathway system assembling fimbriae. Environ Microbiol. 2011;13:666–683. doi: 10.1111/j.1462-2920.2010.02372.x. [DOI] [PubMed] [Google Scholar]
- 46.Goris J, Konstantinidis KT, Klappenbach JA, Coenye T, Vandamme P, et al. DNA-DNA hybridization values and their relationship to whole-genome sequence similarities. Int J Syst Evol Microbiol. 2007;57:81–91. doi: 10.1099/ijs.0.64483-0. [DOI] [PubMed] [Google Scholar]
- 47.Siguier P, Perochon J, Lestrade L, Mahillon J, Chandler M. ISfinder: the reference centre for bacterial insertion sequences. Nucleic Acids Res. 2006;34:D32–D36. doi: 10.1093/nar/gkj014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Castro-Jaimes S, Salgado-Camargo AD, Graña-Miraglia L, Lozano L, Bocanegra-Ibarias P, et al. Complete genome sequence of a multidrug-resistant Acinetobacter baumannii isolate obtained from a mexican hospital (sequence type 422) Genome Announc. 2016;4 doi: 10.1128/genomeA.00583-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Marchler-Bauer A, Bo Y, Han L, He J, Lanczycki CJ, et al. CDD/SPARCLE: functional classification of proteins via subfamily domain architectures. Nucleic Acids Res. 2017;45:D200–D203. doi: 10.1093/nar/gkw1129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Siguier P, Gourbeyre E, Chandler M. Bacterial insertion sequences: their genomic impact and diversity. FEMS Microbiol Rev. 2014;38:865–891. doi: 10.1111/1574-6976.12067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Vandecraen J, Chandler M, Aertsen A, van Houdt R. The impact of insertion sequences on bacterial genome plasticity and adaptability. Crit Rev Microbiol. 2017;43:709–730. doi: 10.1080/1040841X.2017.1303661. [DOI] [PubMed] [Google Scholar]
- 52.Martinez E, Pérez JE, Márquez C, Vilacoba E, Centrón D, et al. Emerging and existing mechanisms co-operate in generating diverse β-lactam resistance phenotypes in geographically dispersed and genetically disparate Pseudomonas aeruginosa strains. J Glob Antimicrob Resist. 2013;1:135–142. doi: 10.1016/j.jgar.2013.03.013. [DOI] [PubMed] [Google Scholar]
- 53.Sun Q, Ba Z, Wu G, Wang W, Lin S, et al. Insertion sequence ISRP10 inactivation of the oprD gene in imipenem-resistant Pseudomonas aeruginosa clinical isolates. Int J Antimicrob Agents. 2016;47:375–379. doi: 10.1016/j.ijantimicag.2016.02.008. [DOI] [PubMed] [Google Scholar]
- 54.Vassilara F, Galani I, Souli M, Papanikolaou K, Giamarellou H, et al. Mechanisms responsible for imipenem resistance among Pseudomonas aeruginosa clinical isolates exposed to imipenem concentrations within the mutant selection window. Diagn Microbiol Infect Dis. 2017;88:276–281. doi: 10.1016/j.diagmicrobio.2017.04.005. [DOI] [PubMed] [Google Scholar]
- 55.Wołkowicz T, Patzer JA, Kamińska W, Gierczyński R, Dzierżanowska D. Distribution of carbapenem resistance mechanisms in Pseudomonas aeruginosa isolates among hospitalised children in Poland: characterisation of two novel insertion sequences disrupting the oprD gene. J Glob Antimicrob Resist. 2016;7:119–125. doi: 10.1016/j.jgar.2016.08.007. [DOI] [PubMed] [Google Scholar]
- 56.Lindberg F, Lindquist S, Normark S. Inactivation of the ampD gene causes semiconstitutive overproduction of the inducible Citrobacter freundii beta-lactamase. J Bacteriol. 1987;169:1923–1928. doi: 10.1128/jb.169.5.1923-1928.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Pérez-Gallego M, Torrens G, Castillo-vera J, Moya B, Zamorano L, et al. Impact of AmpC derepression on fitness and virulence: the mechanism or the pathway? mBio. 2016;7 doi: 10.1128/mBio.01783-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Lee M, Artola-Recolons C, Carrasco-López C, Martínez-Caballero S, Hesek D, et al. Cell-wall remodeling by the zinc-protease AmpDh3 from Pseudomonas aeruginosa . J Am Chem Soc. 2013;135:12604–12607. doi: 10.1021/ja407445x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Vollmer W, von Rechenberg M, Höltje JV. Demonstration of molecular interactions between the murein polymerase PBP1B, the lytic transglycosylase MltA, and the scaffolding protein MipA of Escherichia coli . J Biol Chem. 1999;274:6726–6734. doi: 10.1074/jbc.274.10.6726. [DOI] [PubMed] [Google Scholar]
- 60.Li XZ, Plésiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015;28:337–418. doi: 10.1128/CMR.00117-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Shah P, Swiatlo E. A multifaceted role for polyamines in bacterial pathogens. Mol Microbiol. 2008;68:4–16. doi: 10.1111/j.1365-2958.2008.06126.x. [DOI] [PubMed] [Google Scholar]
- 62.Dean CR, Goldberg JB. Pseudomonas aeruginosa galU is required for a complete lipopolysaccharide core and repairs a secondary mutation in a PA103 (serogroup O11) wbpM mutant. FEMS Microbiol Lett. 2002;210:277–283. doi: 10.1111/j.1574-6968.2002.tb11193.x. [DOI] [PubMed] [Google Scholar]
- 63.Priebe GP, Dean CR, Zaidi T, Meluleni GJ, Coleman FT, et al. The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung. Infect Immun. 2004;72:4224–4232. doi: 10.1128/IAI.72.7.4224-4232.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Arora SK, Bangera M, Lory S, Ramphal R. A genomic island in Pseudomonas aeruginosa carries the determinants of flagellin glycosylation. PNAS USA. 2001;98:9342–9347. doi: 10.1073/pnas.161249198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Feuillet V, Medjane S, Mondor I, Demaria O, Pagni PP, et al. Involvement of toll-like receptor 5 in the recognition of flagellated bacteria. PNAS USA. 2006;103:12487–12492. doi: 10.1073/pnas.0605200103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Tammam S, Sampaleanu LM, Koo J, Manoharan K, Daubaras M, et al. PilMNOPQ from the Pseudomonas aeruginosa type IV pilus system form a transenvelope protein interaction network that interacts with PilA. J Bacteriol. 2013;195:2126–2135. doi: 10.1128/JB.00032-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Basso P, Ragno M, Elsen S, Reboud E, Golovkine G, et al. Pseudomonas aeruginosa Pore-Forming exolysin and Type IV Pili cooperate to induce host cell lysis. mBio. 2017;8 doi: 10.1128/mBio.02250-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Borlee BR, Goldman AD, Murakami K, Samudrala R, Wozniak DJ, et al. Pseudomonas aeruginosa uses a cyclic-di-GMP-regulated adhesin to reinforce the biofilm extracellular matrix. Mol Microbiol. 2010;75:827–842. doi: 10.1111/j.1365-2958.2009.06991.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Faure LM, Garvis S, de Bentzmann S, Bigot S. Characterization of a novel two-partner secretion system implicated in the virulence of Pseudomonas aeruginosa . Microbiology. 2014;160:1940–1952. doi: 10.1099/mic.0.079616-0. [DOI] [PubMed] [Google Scholar]
- 70.Kida Y, Higashimoto Y, Inoue H, Shimizu T, Kuwano K. A novel secreted protease from Pseudomonas aeruginosa activates NF-kappaB through protease-activated receptors. Cell Microbiol. 2008;10:1491–1504. doi: 10.1111/j.1462-5822.2008.01142.x. [DOI] [PubMed] [Google Scholar]
- 71.Melvin JA, Gaston JR, Phillips SN, Springer MJ, Marshall CW, et al. Pseudomonas aeruginosa Contact-Dependent Growth Inhibition Plays Dual Role in Host-Pathogen Interactions. mSphere. 2017;2 doi: 10.1128/mSphere.00336-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Mercy C, Ize B, Salcedo SP, de Bentzmann S, Bigot S. Functional characterization of Pseudomonas Contact dependent growth inhibition (CDI) Systems. PLoS One. 2016;11:e0147435. doi: 10.1371/journal.pone.0147435. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Blumer C, Haas D. Iron regulation of the hcnABC genes encoding hydrogen cyanide synthase depends on the anaerobic regulator ANR rather than on the global activator GacA in Pseudomonas fluorescens CHA0. Microbiology. 2000;146:2417–2424. doi: 10.1099/00221287-146-10-2417. [DOI] [PubMed] [Google Scholar]
- 74.Carterson AJ, Morici LA, Jackson DW, Frisk A, Lizewski SE, et al. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa . J Bacteriol. 2004;186:6837–6844. doi: 10.1128/JB.186.20.6837-6844.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Carroll W, Lenney W, Wang T, Spanel P, Alcock A, et al. Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry. Pediatr Pulmonol. 2005;39:452–456. doi: 10.1002/ppul.20170. [DOI] [PubMed] [Google Scholar]
- 76.Ryall B, Davies JC, Wilson R, Shoemark A, Williams HD. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients. Eur Respir J. 2008;32:740–747. doi: 10.1183/09031936.00159607. [DOI] [PubMed] [Google Scholar]
- 77.Frangipani E, Pérez-Martínez I, Williams HD, Cherbuin G, Haas D. A novel cyanide-inducible gene cluster helps protect Pseudomonas aeruginosa from cyanide. Environ Microbiol Rep. 2014;6:28–34. doi: 10.1111/1758-2229.12105. [DOI] [PubMed] [Google Scholar]
- 78.Hirai T, Osamura T, Ishii M, Arai H. Expression of multiple cbb 3 cytochrome c oxidase isoforms by combinations of multiple isosubunits in Pseudomonas aeruginosa . PNAS USA. 2016;113:12815–12819. doi: 10.1073/pnas.1613308113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Firoved AM, Ornatowski W, Deretic V. Microarray analysis reveals induction of lipoprotein genes in mucoid Pseudomonas aeruginosa: implications for inflammation in cystic fibrosis. Infect Immun. 2004;72:5012–5018. doi: 10.1128/IAI.72.9.5012-5018.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Damron FH, Napper J, Teter MA, Yu HD. Lipotoxin F of Pseudomonas aeruginosa is an AlgU-dependent and alginate-independent outer membrane protein involved in resistance to oxidative stress and adhesion to A549 human lung epithelia. Microbiology. 2009;155:1028–1038. doi: 10.1099/mic.0.025833-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Fortier LC, Sekulovic O. Importance of prophages to evolution and virulence of bacterial pathogens. Virulence. 2013;4:354–365. doi: 10.4161/viru.24498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Winstanley C, Langille MG, Fothergill JL, Kukavica-Ibrulj I, Paradis-Bleau C, et al. Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa. Genome Res. 2009;19:12–23. doi: 10.1101/gr.086082.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Matsui H, Sano Y, Ishihara H, Shinomiya T. Regulation of pyocin genes in Pseudomonas aeruginosa by positive (prtN) and negative (prtR) regulatory genes. J Bacteriol. 1993;175:1257–1263. doi: 10.1128/jb.175.5.1257-1263.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.McFarland KA, Dolben EL, Leroux M, Kambara TK, Ramsey KM, et al. A self-lysis pathway that enhances the virulence of a pathogenic bacterium. PNAS USA. 2015;112:8433–8438. doi: 10.1073/pnas.1506299112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Jatsenko T, Sidorenko J, Saumaa S, Kivisaar M. DNA polymerases ImuC and DinB are involved in DNA alkylation damage tolerance in Pseudomonas aeruginosa and Pseudomonas putida . PLoS One. 2017;12:e0170719. doi: 10.1371/journal.pone.0170719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Oliver A, Cantón R, Campo P, Baquero F, Blázquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science. 2000;288:1251–1253. doi: 10.1126/science.288.5469.1251. [DOI] [PubMed] [Google Scholar]
- 87.Boukerb AM, Decor A, Ribun S, Tabaroni R, Rousset A, et al. Genomic rearrangements and functional diversification of lecA and lecB lectin-coding regions impacting the efficacy of glycomimetics directed against Pseudomonas aeruginosa . Front Microbiol. 2016;7:811. doi: 10.3389/fmicb.2016.00811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Boukerb AM, Marti R, Cournoyer B. Genome sequences of three strains of the Pseudomonas aeruginosa PA7 clade. Genome Announc. 2015;3 doi: 10.1128/genomeA.01366-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Hilker R, Munder A, Klockgether J, Losada PM, Chouvarine P, et al. Interclonal gradient of virulence in the Pseudomonas aeruginosa pangenome from disease and environment. Environ Microbiol. 2015;17:29–46. doi: 10.1111/1462-2920.12606. [DOI] [PubMed] [Google Scholar]
- 90.Rau MH, Marvig RL, Ehrlich GD, Molin S, Jelsbak L. Deletion and acquisition of genomic content during early stage adaptation of Pseudomonas aeruginosa to a human host environment. Environ Microbiol. 2012;14:2200–2211. doi: 10.1111/j.1462-2920.2012.02795.x. [DOI] [PubMed] [Google Scholar]
- 91.Gaffé J, McKenzie C, Maharjan RP, Coursange E, Ferenci T, et al. Insertion sequence-driven evolution of Escherichia coli in chemostats. J Mol Evol. 2011;72:398–412. doi: 10.1007/s00239-011-9439-2. [DOI] [PubMed] [Google Scholar]
- 92.Raeside C, Gaffé J, Deatherage DE, Tenaillon O, Briska AM, et al. Large chromosomal rearrangements during a long-term evolution experiment with Escherichia coli . mBio. 2014;5:e01377. doi: 10.1128/mBio.01377-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Marvig RL, Sommer LM, Molin S, Johansen HK. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat Genet. 2015;47:57–64. doi: 10.1038/ng.3148. [DOI] [PubMed] [Google Scholar]
- 94.Roach DJ, Burton JN, Lee C, Stackhouse B, Butler-Wu SM, et al. A year of infection in the intensive care unit: prospective whole genome sequencing of bacterial clinical isolates reveals cryptic transmissions and novel microbiota. PLoS Genet. 2015;11:e1005413. doi: 10.1371/journal.pgen.1005413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Vincent AT, Freschi L, Jeukens J, Kukavica-Ibrulj I, Emond-Rheault JG, et al. Genomic characterisation of environmental Pseudomonas aeruginosa isolated from dental unit waterlines revealed the insertion sequence ISPa11 as a chaotropic element. FEMS Microbiol Ecol. 2017;93 doi: 10.1093/femsec/fix106. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.